Research & Development
Prevencio, Alivio Health to expand cardiac test access
The coverage includes Prevencio's Hart CVE, a blood test for assessing a patient's one-year risk for a heart attack, stroke, or cardiac death, and Hart CADhs, for assessing a patient's risk for significant blockage of a heart artery.
July 18, 2022
Flu shots may protect against severe COVID-19
The annual flu shot may reduce the risks of stroke, sepsis, and deep vein thrombosis (DVT) in patients with COVID-19. Also, those who received influenza vaccines were significantly less likely to visit emergency departments and be admitted to intensive care units, according to the findings.
August 3, 2021
NanoDx inks deal with IBM, seeks EUA for COVID-19 test
Under the deal, NanoDx will get use of IBM's complementary metal oxide semiconductor (CMOS)-compatible nanoscale sensors to enhance and expand rapid testing for conditions such as sepsis, stroke, traumatic brain injury, and COVID-19.
July 13, 2021
Blood test for sex hormone protein signals stroke risk
The study evaluated the link between the protein and risk for ischemic stroke in a cohort of more than 13,000 women who had been WHI participants and had been followed long term. The findings are slated to be shared in an oral presentation at the International Stroke Conference, which runs from February 19-21 in Los Angeles.
February 12, 2020
Pathology study challenges conventional wisdom on brain injury
The prospective Traumatic Head Injury Neuroimaging Classification (THINC) study was funded by the U.S. Department of Defense and the National Institute of Neurological Disorders and Stroke (NINDS).
October 14, 2019
FYR gets NIH small business grant for epilepsy diagnostics
The grant was awarded by the NIH's National Institute of Neurological Disorders and Stroke, through the government's Small Business Innovation Research program. In the first phase of the funding, FYR Diagnostics will develop biomarkers for use in diagnostic kits.
October 9, 2019
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
National hepatitis C elimination program represents an historic opportunity, according to White House
Chicago man indicted for COVID-19 testing fraud
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Intensive blood sugar control has low value in acute stroke
The trial -- dubbed the Stroke Hyperglycemia Insulin Network Effort (SHINE) -- compared intensive and standard blood glucose control using insulin in 1,151 acute stroke patients and showed good outcomes for 20% in both cohorts, Dr. Karen Johnston, chair of neurology at the University of Virginia, and colleagues reported (JAMA, July 23/30, 2019, Vol. 322:4, pp. 326-335).
July 23, 2019
Page 1 of 1